Our regular readers will know Maly is a company which specialises in helping innovators simplify, digitise, automate and control complex industrial and compliance processes. The Okuda no-code tool allows users to model and capture any process as a series of simple digital steps, ensuring each individual and team plays their part at the right time […]
Norfolk Hospital Joins Groundbreaking Generation Study Here at Maly IT, we’re really pleased to hear that our local Norfolk and Norwich University Hospital (NNUH) is taking part in the pioneering Generation Study. This national research project aims to transform how over 200 rare genetic conditions are diagnosed in newborns. The study will offer whole genome
Building upon Part 1’s exploration of product labelling as a defence against counterfeiting, this article (Part 2) delves into the intricate process of managing pharmaceutical labelling changes, crucial for compliance, minimising waste, and maintaining efficient supply chains across multiple markets. The seemingly simple act of changing a word or updating a logo on a pharmaceutical
The biopharmaceutical landscape is undergoing a significant transformation, driven by the increasing reliance on in silico simulations in drug discovery and therapeutics development. This computational approach offers a powerful tool for researchers. It allows for the prediction of drug-target interactions. Lead compounds can be optimised. The behaviour of molecules within biological systems can be simulated.
Credit: International Institute for Management Development (IMD) This February, I have decided to return to the topic of future readiness of pharmaceutical companies. It is a topic which has been gnawing away at me for well over a year, even before I first wrote about it (see Pulse 19 March 2024). Future readiness – a
Process innovation involves the introduction of new or significantly improved production techniques, equipment, or software, fundamentally changing how products are made. In advanced manufacturing, this can mean the integration of robotics, artificial intelligence (AI), and data analytics to optimize operations & enhance productivity. Benefits include: Increased Productivity – By automating repetitive tasks & using advanced
Process compliance is crucial in new drug development and testing as it ensures that all regulatory requirements are met at each stage, from discovery to post-marketing surveillance. Compliance involves rigorous scientific research, data integrity, and adherence to Good Manufacturing Practices (GMP) and regulatory submissions such as the Clinical Trial Application (CTA) (Investigational New Drug –
Our appetite for Fast Fashion is insatiable. Over half of the clothes we buy on the UK high street we’re made in very low income countries with workers paid as little as 13p per hour. Often those workers are effectively modern day slaves with many being children. And yet according to a recent poll 7
Failure to follow processes or comply with regulations can be costly in any industry. But in thespace sector the results of process failure can be catastrophic. Failure in quality control processes have lead to significant mission failures such as the loss of the Mars Climate Orbiter mission in 1999 (failure to track and double-check all interconnected aspects
We’ve been rather busy over the last 12 months helping to develop, deploy and support a new digital platform called Cerberus for our client Insight-Regulatory! Cerberus is designed to help financial services companies manage the stringent governance requirements, senior management responsibilities and complex reporting processes associated with SMCR regulations – which for financial services companies, who manage thousands of financial
